Better Therapeutics, Inc. (BTTX)
Creates prescription therapy software that helps patients manage diabetes and heart disease.
$0.00+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+0.0%
The outlook
BTTX is trading at its 52-week low with a mixed technical picture relative to its moving averages. Analyst coverage is thin, and the overall data leans bearish. The stock shows minimal price movement today.
What’s behind the score
Price trendMixed vs its moving averages
52-week range0% of the way from its 52-week low to high
Market cap
$5,451
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—